Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metaplanet | OTC Markets | 367.8% | $688Cr | 292.5x | 3.87 | $10.65 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
ABVC Biopharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 219% | $7.61Cr | -7.9x | -0.31 | $3.35 | -28.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IREN Ltd | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 208.9% | $410Cr | -45.5x | 1.94 | $17.04 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.8% Upside | Upgrade to Pro+ | |
Nuscale Power | NYSE | Utilities | Electrical Utilities & IPPs | 138.8% | $1.01KCr | -17x | 0.69 | $36.02 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Ascentage Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 136.6% | $352Cr | -30.1x | -1.08 | $40.74 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -33.1% Downside | Upgrade to Pro+ | |
Robinhood Markets | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 133.4% | $8.65KCr | 54.5x | 0.05 | $98.73 | 4.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.8% Downside | Upgrade to Pro+ | |
Phathom Pharma | NASDAQ | Healthcare | Pharmaceuticals | 128% | $67.42Cr | -1.8x | 0.11 | $9.69 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
D Wave Quantum | NYSE | Technology | Software & IT Services | 127.6% | $504Cr | -27.4x | 2.57 | $16.01 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.8% Upside | Upgrade to Pro+ | |
Septerna | NASDAQ | Healthcare | Biotechnology & Medical Research | 127.1% | $52.13Cr | -3x | 0.06 | $11.68 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Coinbase Global | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 120.4% | $9.86KCr | 66.1x | 12.7 | $388.96 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -24.8% Downside | Upgrade to Pro+ | |
ProQR Therapeutics NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 103.5% | $24.81Cr | -6.1x | 3.97 | $2.36 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Reserve Inc | OTC Markets | Industrials | Professional & Commercial Services | 97.7% | $40.53Cr | -17.6x | -1.56 | $3.62 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuanbao | NASDAQ | 93.3% | $139Cr | 6.5x | 0.06 | $29.67 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
CureVac NV | NASDAQ | Healthcare | Biotechnology & Medical Research | 92.3% | $123Cr | 5.8x | 0.04 | $5.45 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.4% Downside | Upgrade to Pro+ | |
Hims Hers Health | NYSE | Healthcare | Healthcare Providers & Services | 91.1% | $1.12KCr | 66.9x | 0.01 | $50.27 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -14.1% Downside | Upgrade to Pro+ | |
Futu | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 90.3% | $1.99KCr | 23.8x | 0.41 | $143.49 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.6% Upside | Upgrade to Pro+ | |
Argo Corp | OTC Markets | Technology | Software & IT Services | 86.9% | $5.78Cr | -0.06 | $0.43 | 5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Stoke Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 84.4% | $65.90Cr | 13.6x | 0.1 | $12.04 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Critical Metals Corp | NASDAQ | Basic Materials | Metals & Mining | 83.8% | $29.32Cr | -1x | $3.04 | 7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Ast Spacemobile | NASDAQ | Technology | Telecommunications Services | 83.7% | $1.48KCr | -24.5x | 0.37 | $44 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
51Talk Online Education DRC | NYSE | Academic & Educational Services | Miscellaneous Educational Service Providers | 82.7% | $17Cr | -37x | -0.51 | $29 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kuros Biosciences | OTC Markets | Healthcare | Biotechnology & Medical Research | 70.5% | $134Cr | -278.3x | -4.05 | $35.80 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arrowhead Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 69.9% | $260Cr | -16.7x | -0.25 | $18.86 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astera Labs | NASDAQ | Technology | Semiconductors & Semiconductor Equipment | 69.7% | $1.65KCr | 280x | 3.6 | $97.02 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
Regenxbio Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | 69.5% | $45.70Cr | -2.9x | -0.06 | $9.06 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Royalty | NYSE | Financial | Investment Banking & Investment Services | 61.9% | $40.49Cr | -121.4x | -1.41 | $2.37 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.8% Upside | Upgrade to Pro+ | |
Blueprint Medicines Corp | NASDAQ | Healthcare | Biotechnology & Medical Research | 60.1% | $837Cr | -52.7x | -1.11 | $129.33 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.4% Upside | Upgrade to Pro+ | |
Up Fintech | NASDAQ | Financial | Investment Banking & Investment Services | 52.5% | $181Cr | 21.4x | 0.24 | $10.25 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.5% Upside | Upgrade to Pro+ | |
Abivax ADR | NASDAQ | Healthcare | Biotechnology & Medical Research | 48.7% | $52.44Cr | -0.21 | $8.30 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Sailfish Royalty | OTC Markets | Basic Materials | Metals & Mining | 47.2% | $13.63Cr | 165.3x | 0.87 | $1.82 | 6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NewAmsterdam Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 45.2% | $246Cr | -11.9x | -0.4 | $22.02 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Himalaya Shipping | NYSE | Industrials | Freight & Logistics Services | 44.2% | $30.80Cr | 20.1x | 0.13 | $6.63 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.8% Upside | Upgrade to Pro+ | |
NYSE | Technology | Software & IT Services | 42.8% | $2.69KCr | 232x | 2.15 | $143 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3% Upside | Upgrade to Pro+ | ||
Capital Clean Energy | NASDAQ | Industrials | Freight & Logistics Services | 42.1% | $141Cr | 41.3x | 0.95 | $24.20 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.1% Upside | Upgrade to Pro+ | |
Elron Electronic Industries | OTC Markets | Financial | Investment Banking & Investment Services | 40.7% | $8.12Cr | 4x | 0.01 | $1.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XOMA | NASDAQ | Consumer Cyclicals | Media & Publishing | 40.7% | $33.28Cr | -39.2x | -0.47 | $27.90 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dominari Holdings | NASDAQ | Financial | Investment Banking & Investment Services | 40% | $6.93Cr | -0.8x | 0.07 | $4.78 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DeFi Tech | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 38.3% | $92.82Cr | 55.8x | 0.32 | $2.95 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mirum Pharmaceuticals | NASDAQ | Healthcare | Pharmaceuticals | 36.7% | $262Cr | -33.2x | -0.61 | $53.01 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.6% Upside | Upgrade to Pro+ | |
Volitionrx Ltd | NYSE | Healthcare | Biotechnology & Medical Research | 36.6% | $7.01Cr | -2.5x | -0.07 | $0.68 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ares Commercial RE | NYSE | Real Estate | Residential & Commercial REITs | 35.9% | $26.72Cr | -19.9x | -0.28 | $4.84 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
Financial 15 | OTC Markets | Financial | Collective Investments | 35.3% | $44.30Cr | 1.7x | $7.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ARS Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 35.2% | $176Cr | -112x | -1.63 | $17.98 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dianthus Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 35.2% | $66.48Cr | -7.4x | -0.18 | $20.61 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avadel Pharma | NASDAQ | Healthcare | Pharmaceuticals | 33.9% | $92.54Cr | -34.3x | -0.41 | $9.79 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vista Oil Gas | NYSE | Energy | Oil & Gas | 33.9% | $516Cr | 9.8x | 0.31 | $48.92 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.2% Upside | Upgrade to Pro+ | |
Biostem Tech | OTC Markets | Healthcare | Pharmaceuticals | 33.7% | $20.50Cr | 9.6x | 0 | $12.45 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | NASDAQ | Healthcare | Biotechnology & Medical Research | 32.1% | $11.27Cr | -2.5x | -0.03 | $1.65 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Fund | NYSE | Financial | Collective Investments | 31.2% | $14.91Cr | 7.7x | $14.92 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Dividend 15 Split | OTC Markets | Financial | Investment Banking & Investment Services | 29.9% | $61.13Cr | 1.9x | $4.56 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |